DJIA 17,776.12 -200.19 -1.11%
NASDAQ 4,900.89 -46.56 -0.94%
S&P 500 2,067.89 -18.35 -0.88%
market minute promo

Novo Nordisk (NYSE: NVO)

53.39 -1.29 (-2.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVO $53.39 -2.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.58
Previous Close $54.68
Daily Range $53.36 - $54.15
52-Week Range $41.72 - $54.95
Market Cap $141.5B
P/E Ratio 0.00
Dividend (Yield) $0.00 (1.0%)
Volume 2,784,849
Average Daily Volume 1,840,690
Current FY EPS $1.85

Sector

Healthcare

Industry

Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

Too Good to Be True? Proceed With Caution on These 2 Biotechs

All that glitters is not gold, and sometimes a much-hyped biotech isn’t quite as sparkly once you scratch the surface.

Top First Quarter European ETFs

European ADRs Slide as Miners Contract

Type 1 Diabetes, Progress With Stem Cells And Other Cell-Based Therapies

European ADRs Start the Week Higher Despite Mixed Results for Pharma Stocks

Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog

Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog

Pre-Market Most Active for Mar 27, 2015 : BBRY, DOW, NVO, SAP, SDRL, OREX, XIV, SCAI, AAPL, TPVG, M

Pre-Market Most Active for Mar 27, 2015 : BBRY, DOW, NVO, SAP, SDRL, OREX, XIV, SCAI, AAPL, TPVG, MT, BMRN

Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog

Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog

Novo Nordisk (NVO) Stock Gains Today on Drug Application Resubmission

See More NVO News...

NVO's Top Competitors

NVO $53.39 (-2.36%)
Current stock: NVO
JNJ $100.60 (-0.94%)
Current stock: JNJ
NVS $98.61 (-2.67%)
Current stock: NVS
RHHBY $34.38 (0.50%)
Current stock: RHHBY